How Much Alpha-Lipoic Acid Per Day, and When to Take It

The short answer

The number that runs through this entire field is 600 mg per day, and it comes from a specific place. SYDNEY 2 randomized patients to 600, 1,200, or 1,800 mg of oral alpha-lipoic acid daily. All three doses improved symptom scores by almost exactly the same amount. What rose with dose was nausea, vomiting, and vertigo. The authors concluded 600 mg once daily gave the best risk-to-benefit ratio, and that is why nearly every capsule on the shelf holds 600 mg.

On timing, the evidence is thinner but pulls in one clear direction: take it on an empty stomach, roughly 30 minutes before a meal or two hours after. Food does not just delay absorption, it reduces it, and alpha-lipoic acid starts from a low base of about 30 percent absolute bioavailability. The specific hour of the day matters far less than being fasted when you take it.

This article describes what the research used. It is not a protocol, and alpha-lipoic acid has a real interaction with blood sugar that makes the dose question a clinician’s question for a lot of people. For the underlying evidence, see the alpha-lipoic acid pillar.

Where 600 mg came from

SYDNEY 2 is worth looking at closely, because it is unusual: a trial that tested three doses of a supplement head to head, and found the dose-response curve was flat while the side-effect curve was not.

Daily oral dose	Symptom score improvement	Responders (50%+ reduction)
Placebo	32%	26%
600 mg	51%	62%
1,200 mg	48%	50%
1,800 mg	52%	56%

Tripling the dose bought nothing. The 600 mg group did marginally best on response rate, which is almost certainly noise, but the honest reading is that these three groups performed the same while nausea, vomiting, and vertigo climbed steadily with dose. That is the whole argument for 600 mg, and it is a good one.

⚠ CLAIM (wellness-guidance): In SYDNEY 2, oral alpha-lipoic acid at 600, 1,200, and 1,800 mg daily improved diabetic neuropathy symptom scores similarly and better than placebo, with dose-dependent gastrointestinal side effects, leading the authors to identify 600 mg once daily as the best risk-to-benefit ratio. This was a five-week trial in patients with diagnosed diabetic polyneuropathy, not a general wellness dosing recommendation. Basis: Ziegler 2006, Diabetes Care. Lane: wellness-guidance.

Two pieces of context keep this honest. First, that trial studied people with diabetic polyneuropathy, and the outcome measured was nerve symptoms. It does not establish that 600 mg is the right amount for a healthy person taking ALA as a general antioxidant, because nobody has run that study. Second, the longer-term picture is less flattering: NATHAN 1 gave 600 mg daily for four years and missed its primary endpoint, a composite neuropathy score, at p = 0.105. Some secondary measures did favour ALA. A four-year trial that misses its primary endpoint is a result worth sitting with rather than skipping past.

Doses used in other research

Outside neuropathy, the doses studied vary and the results are more modest.

• Weight: a meta-analysis of ten randomized placebo-controlled trials found ALA produced about 1.27 kg more weight loss than placebo, with a BMI difference of 0.40 kg/m². Doses across those trials ranged widely, commonly 300 to 1,800 mg daily. A kilogram and a bit is a real effect and a small one.
• Blood sugar and insulin sensitivity: studied mostly at 600 to 1,200 mg daily, with mixed and generally modest results.
• General antioxidant or longevity use: no established dose, because there are no outcome trials. People extrapolate from the 600 mg neuropathy figure, which is an assumption rather than a finding.

The pattern across the literature is that more has not meant better in any context where it has been tested directly. That is unusual and it is worth taking seriously, because the intuition that a bigger dose should do more is exactly what SYDNEY 2 tested and did not find.

Why the empty stomach rule is the one that matters

Alpha-lipoic acid is absorbed quickly and then largely destroyed on arrival. It is well taken up from the gut, but its absolute oral bioavailability is only around 30 percent, chiefly because the liver extracts most of it on first pass. Plasma concentrations peak within about an hour and fall away quickly.

Against that background, food is a meaningful loss. When Gleiter and colleagues gave thioctic acid with and without a meal, time to peak stretched to roughly 2.5 hours in the fed state against about 1 hour fasted, alongside reduced bioavailability. You are taking a compound that only delivers about a third of its dose in the best case, and eating with it makes that worse.

Practically: 30 minutes before a meal, or two hours after one. That single habit does more for how much you actually absorb than any choice between forms, which we cover in R-ALA vs alpha-lipoic acid.

Should you take alpha-lipoic acid before bed?

This gets asked a lot, and the popularity of the idea has a mundane explanation: bedtime is the easiest time of day to be genuinely fasted. If you last ate at seven and go to bed at eleven, the empty-stomach requirement takes care of itself, with no meal-planning around a capsule.

So the honest answer is that there is no evidence bedtime is inherently better, and no trial has compared morning against evening dosing for any outcome. What bedtime does is make compliance with the rule that actually matters easier.

There is one real reason to think twice. Alpha-lipoic acid can lower blood sugar. For most people that is unremarkable, but if you take insulin or a sulfonylurea, or you have any history of hypoglycemia, the overnight hours are the worst window in which to add a mild glucose-lowering effect, because you are asleep and cannot notice symptoms. In that situation the timing question stops being about absorption and becomes a safety question for your clinician, not an optimization choice.

⚠ CLAIM (wellness-guidance): Alpha-lipoic acid can lower blood glucose and may have additive effects with diabetes medications, so anyone using insulin or sulfonylureas should discuss timing and use with a clinician before taking it, particularly at night. Basis: Shay 2009 review; documented ALA and insulin autoimmune syndrome case reports. Lane: wellness-guidance.

A smaller consideration: a minority of people find ALA mildly stimulating or report vivid dreams, and others find nothing of the sort. There is no trial evidence either way. If you try it at night and sleep worse, move it to the morning; this is one of the rare cases where personal trial and error is genuinely more informative than the literature, because the literature is silent.

Once a day or split?

The pharmacokinetics make a superficial case for splitting. Alpha-lipoic acid clears fast, so 300 mg twice daily keeps something in circulation for more of the day than 600 mg once. Some people take it that way, and it is not unreasonable.

But the trials that produced the evidence used once-daily dosing, including both SYDNEY 2 and NATHAN 1, and there is no outcome evidence that splitting improves anything. There is also a mechanistic reason not to assume it would. ALA’s more interesting effects appear to be signalling effects, notably activation of the Nrf2 pathway discussed in sulforaphane and Nrf2, and a signalling pulse does not necessarily need sustained blood levels to do its work. Splitting also doubles the number of times a day you have to be fasted, which in practice is where people give up.

Upper limits and where the real risk sits

The safety story here has an unusual shape, and it is the reason “start low, go slow” does not fully apply.

The dose-dependent problems are the mild ones. Nausea, vomiting, vertigo, heartburn, and rash climb with dose, which is exactly what SYDNEY 2 showed. If those are your only concern, staying at 600 mg or below handles it.

The serious problem does not follow that rule. Alpha-lipoic acid is linked to insulin autoimmune syndrome, a rare autoimmune cause of hypoglycemia in which the body makes antibodies against its own insulin. Reviewing 49 published cases, EFSA highlighted a strong genetic component, associated with particular HLA-DRB1 alleles, HLA-DRB1*04:06 notably in Japanese populations and *04:03 in Europeans, and took the position that because the reaction is immunological, dose is probably not the deciding factor. You cannot reliably dose your way around it. Unexplained hypoglycemia while taking ALA is a reason to stop and see a doctor, not a reason to halve the capsule.

Finally, acute overdose is genuinely dangerous, which is easy to forget for something sold beside the vitamin C. Published case reports describe seizures, status epilepticus, coagulopathy, multi-organ failure, and deaths, in children after accidental ingestion and in at least one adult, with serious toxicity clustering around ingestions of several grams and one report of severe effects near 30 mg/kg. Keep the bottle in a child-resistant container and out of reach. That is not a generic safety line, it is the specific documented hazard of this compound.

The bottom line

Six hundred milligrams a day, taken on an empty stomach, once daily, is the pattern the research actually used, and there is no evidence that exceeding it helps. If you are taking ALA for general wellness rather than a diagnosed condition, be aware that you are extrapolating from neuropathy trials, and that the compound’s four-year trial missed its primary endpoint. Sensible expectations belong alongside a sensible dose, which is the framing we use throughout our evidence-graded supplement guide. Which product actually delivers that 600 mg intact is a separate question, covered in the alpha-lipoic acid buying guide. If you have diabetes, take insulin, or have any history of hypoglycemia, this is a conversation to have with a clinician rather than a decision to make from an article.

Educational information only, not medical advice, and not evaluated by the FDA. Alpha-lipoic acid is not a treatment for any disease, and the doses described here are a summary of what published trials administered, not a recommendation or a protocol. Talk to a clinician before supplementing, particularly if you take diabetes medication or insulin, have thyroid disease, are pregnant or breastfeeding, have a history of hypoglycemia, or drink heavily, since alpha-lipoic acid can unmask thiamine deficiency. Keep supplements out of reach of children.